Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-14 1:48 pm Purchase | 13G | GUIDED THERAPEUTICS GTHP | Auctus Fund Management LLC | 5,342,840 9.900% | 397,043 (+8.03%) | View |
2024-02-14 1:44 pm Purchase | 13G | BioRestorative Therapies Inc. BRTX | Auctus Fund Management LLC | 482,315 9.900% | 106,311 (+28.27%) | View |
2024-02-14 1:35 pm Sale | 13G | UNIVERSAL SEC INSTRUMENTS INC UUU | Auctus Fund Management LLC | 0 0.000% | -200,000 (Position Closed) | View |
2023-02-14 1:02 pm Purchase | 13G | BioRestorative Therapies Inc. BRTX | Auctus Fund Management LLC | 376,004 9.900% | 166,004 (+79.05%) | View |
2023-02-14 12:54 pm Purchase | 13G | GUIDED THERAPEUTICS GTHP | Auctus Fund Management LLC | 4,945,797 9.900% | 190,699 (+4.01%) | View |
2023-02-14 12:36 pm Unchanged | 13G | UNIVERSAL SEC INSTRUMENTS INC UUU | Auctus Fund Management LLC | 200,000 8.600% | 0 (Unchanged) | View |
2022-10-24 4:17 pm Purchase | 13G | GUIDED THERAPEUTICS GTHP | Auctus Fund Management LLC | 4,755,098 9.900% | 4,755,098 (New Position) | View |
2022-07-14 5:26 pm Purchase | 13G | BioRestorative Therapies Inc. BRTX | Auctus Fund Management LLC | 210,000 5.800% | 210,000 (New Position) | View |
2022-03-11 4:53 pm Purchase | 13G | UNIVERSAL SEC INSTRUMENTS INC UUU | Auctus Fund Management LLC | 200,000 8.650% | 200,000 (New Position) | View |